FY2025 · ended Dec 31, 2025 · Revenue $747.14M, +26.2% YoY · Filed Feb 19, 2026
iRhythm Holdings, Inc. (IRTC) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $747.1 million and a net loss of $44.6 million. Free cash flow was $34.5 million. As of Sep 30, 2026 it held $635.2 million in cash and investments and $73.9 million in total debt.
Revenue (TTM)
$854.04M
+21.6% vs year-ago TTM
Net income (TTM)
$-38.59M
+25.0% vs year-ago TTM
Operating cash flow (TTM)
$55.56M
-24.8% vs year-ago TTM
Free cash flow (TTM)
$7.38M
-77.2% vs year-ago TTM
EPS (TTM)
$-1.18
+27.1% vs year-ago TTM
Dividend per share
None
Shares outstanding
32.32M
+2.9% vs prior year
Net cash
$561.36M
as of Sep 30, 2026
Operating margin
-5.7%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- IRTC (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- San Francisco, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1388658
- Former names
- IRhythm Technologies, Inc. (until Jan 12, 2026); iRhythm Technologies, Inc. (until Jan 12, 2026); IRhythm Technologies Inc (until May 18, 2010)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $747.1M | $591.8M | $492.7M | $410.9M | $322.8M |
| Operating income | -$57.4M | -$115.5M | -$125.2M | -$113.8M | -$99.9M |
| Net income | -$44.6M | -$113.3M | -$123.4M | -$116.2M | -$101.4M |
| Diluted EPS | -$1.39 | -$3.63 | -$4.04 | -$3.88 | -$3.46 |
| Operating cash flow | $80.9M | $3.4M | -$50.1M | -$23.0M | -$37.8M |
| Free cash flow | $34.5M | -$30.6M | -$90.5M | -$52.8M | -$65.8M |
| Total assets | $1.0B | $931.4M | $433.1M | $448.2M | $463.0M |
| Total liabilities | $867.3M | $840.5M | $223.0M | $208.4M | $183.5M |
| Stockholders' equity | $152.7M | $90.9M | $210.1M | $239.8M | $279.5M |
| Cash and investments | $653.7M | $597.5M | $133.8M | $213.1M | $239.1M |
| Total debt | $81.7M | $90.5M | $129.8M | $131.0M | $117.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 5, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 22, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 13, 2026 | Aug 11, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 6, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Jul 31, 2026 |
All 849 iRhythm Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.